First HIV prevention drug for high-risk groups approved in EU

July 22 20:48 2016

The first drug designed to help to prevent HIV
transmission in people at high risk of infection was
approved for use in the European Union on Friday.
The European Medicines Agency (EMA) approved the
use of the drug Truvada for pre-exposure prophylaxis,
or PrEP, in combination with safer sex practices.

The London based agency said that PrEP is
recommended by the World Health Organisation
“The drug will help people who do not have HIV but
who are at high risk of infection with HIV to lower their
chances of becoming infected when they are exposed
to the virus.
“The oral drug should be used in combination with
condoms as part of an HIV prevention strategy.

“Truvada was previously approved for use in the EU as
part of drug cocktails designed to treat people infected
with HIV,’’ the WHO said.
The WHO estimates that some 36.7 million people
worldwide were living with HIV at the end of 2015.